According to Zhitong Finance, Hong Kong's Hang Seng Index rose 0.83% to 23,542 points in midday trading on July 6, while the Hang Seng Tech Index climbed 1.16%. Midday trading volume reached 186.2 billion Hong Kong dollars.
The uptick was driven by a regulatory update: China's drug regulator recently released draft guidelines optimizing the review and approval process for cell and gene therapy drugs, covering measures to encourage innovation and streamline clinical trials. The Hang Seng BioTech Innovation Index surged 2.99% in response, with major biotech stocks gaining sharply.